AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 31702655
Drug: SIP with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SIP with concurrent auditory cues (AC condition)
Trial: 27341793
Drug: Intervention sites
RxNorm normalized name: PAD,BITE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention sites with quarterly workplace assessments and offering HIV treatment at OHUs
Trial: 23468262
Drug: 1 µg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 µg/kg bolus of remifentanil
Trial: 23468262
Drug: 0.5 µg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 µg/kg bolus of remifentanil
Trial: 21575095
Drug: Subcutaneous injection
RxNorm normalized name: EPINEPHRINE 0.3 mg SUBCUTANEOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous injection of differentiated adipocytes
Trial: 8846523
Drug: Calcium acetate
RxNorm normalized name: Calcium Acetate
DrugBank: Calcium sulfate (DB15533)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium acetate (5.04 ± 0.60 g daily, 10.1 ± 1.20 tablets of 500 mg)
Trial: 8846523
Drug: Calcium carbonate
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium carbonate (2.71 ± 0.48 g daily, 5.4 ± 0.95 capsules of 500 mg) with aluminum hydroxide (0.69 ± 0.27 g daily, 1.4 ± 0.55 tablets of 500 mg)
Trial: 27707807
Drug: Oka/Merck varicella
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oka/Merck varicella vaccine
Trial: 6742382
Drug: prilocaine 0.5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: prilocaine 0.5% with octapressin 0.03 iu per ml
Trial: 26266260
Drug: Vaginal Zataria
RxNorm normalized name: Saiga tatarica horn extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal Zataria multiflora cream
Trial: 26266260
Drug: Oral metronidazole
RxNorm normalized name: Metronidazole
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral metronidazole pill
Trial: 23396375
Drug: Newly developed
RxNorm normalized name: petrolatum
DrugBank: Petrolatum (DB11058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Newly developed generic formulation of S-1 (40 mg/m(2), po)
Trial: 23396375
Drug: Branded reference
RxNorm normalized name: Eagle Brand Medicated Oil
DrugBank: Eucalyptus oil (DB11114)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Branded reference formulation of S-1 (40 mg/m(2), po)
Trial: 23396375
Drug: Both formulations
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both formulations of S-1
Trial: 19519724
Drug: Intravenous magnesium
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous magnesium sulfate (8 mg/kg)
Trial: 8794428
Drug: Hormonal replacement
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormonal replacement treatment (HRT) with transdermal 17 beta‐estradiol, 50 mg/day for 24 days/month and medroxiprogesterone, 10 mg for 12 days
Trial: 8794428
Drug: Calcium treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium treatment with elemental calcium, 1 g/day
Trial: 8794428
Drug: Eel calcitonin
RxNorm normalized name: Calcitonin eel
DrugBank: Calcitonin eel (DB12898)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eel calcitonin treatment with 40 IU/day for 10 days/month and elemental calcium, 500 mg/day
Trial: 814955
Drug: 1% silver
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% silver sulphadiazine cream (SSD)
Trial: 814955
Drug: 0.5% silver
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% silver nitrate and 0.2% chlorhexidine digluconate cream (SNC)
Trial: 26119844
Drug: Calcium plus
RxNorm normalized name: O Calcium Plus D
DrugBank: Cupric oxide (DB11134)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium plus vitamin D supplementation (1000 mg calcium daily plus 50000 IU vitamin D weekly)
Trial: 26119844
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D alone (50000 IU weekly)
Trial: 26119844
Drug: Placebo (calcium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (calcium placebo daily plus vitamin D placebo weekly)
Trial: 16785331
Drug: valsartan (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: valsartan (80 to 160 mg)
Trial: 15280154
Drug: Acipimox (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acipimox (250 mg orally four times daily)
Trial: 3103761
Drug: Slow Sodium
RxNorm normalized name: Slow Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow Sodium tablets (100 mmol sodium chloride)
Trial: 31268376
Drug: Sarilumab 150
RxNorm normalized name: SARILUMAB 150MG/1.14ML INJ SYR 1.14ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sarilumab 150 mg q2w + csDMARDs
Trial: 31268376
Drug: Sarilumab 200
RxNorm normalized name: SARILUMAB 200MG/1.14ML INJ SYR 1.14ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sarilumab 200 mg q2w + csDMARDs
Trial: 26603250
Drug: Non‐directive supportive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non‐directive supportive therapy (NDST)
Trial: 18534136
Drug: Combination pharmacological
RxNorm normalized name: COPD pharmacologic substance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination pharmacological cardioversion therapy with low‐dose oral amiodarone (2 mg/kg), captopril (0.25 mg/kg), and simvastatin (0.3 mg/kg) administered daily
Trial: 12450897
Drug: 1 mmol
RxNorm normalized name: monobasic potassium phosphate 1 MMOL/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mmol glycine/kg lean body mass + 25 g glucose
Trial: 10512559
Drug: Low-fat diet
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-fat diet intervention (group sessions weekly for 6 weeks, biweekly for 6 weeks, and monthly for 9 months)
Trial: 8745134
Drug: Bupropion HCL
RxNorm normalized name: bupropion HCl
DrugBank: Bupropion (DB01156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bupropion HCL (300 mg/day)
Trial: 2029827
Drug: Allopurinol riboside,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allopurinol riboside, 25 mg/kg q.i.d. for 13 doses
Trial: 28631923
Drug: Flavonoid-rich supplement
RxNorm normalized name: Maltose-rich malted barley extract
DrugBank: Barley malt syrup (DB14601)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flavonoid-rich supplement (329 mg/d)
Trial: 28631923
Drug: Flavonoid-rich supplement
RxNorm normalized name: Maltose-rich malted barley extract
DrugBank: Barley malt syrup (DB14601)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flavonoid-rich supplement
Trial: 24055998
Drug: Twice a
RxNorm normalized name: Pataday Twice A Day Relief
DrugBank: Olopatadine (DB00768)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice a week assessment of home spirometry and CF respiratory symptoms using an electronic device
Trial: 21335941
Drug: Lidocaine suppository
RxNorm normalized name: lidocaine Rectal Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine suppository (60 mg)
Trial: 17471064
Drug: Sham analgesic
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham analgesic cream
Trial: 17471064
Drug: Inactive cream
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactive cream
Trial: 17471064
Drug: Inactive cream
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactive cream (control)
Trial: 15190832
Drug: Biological organic
RxNorm normalized name: Organix Complete
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biological organic zinc after routine antibiotic treatment
Trial: 15190832
Drug: Routine antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine antibiotic treatment only
Trial: 2504265
Drug: Intravenous fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous fentanyl 50 micrograms
Trial: 31344296
Drug: HPC-NL +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HPC-NL + B (10 mg/daily)
Trial: 26167637
Drug: Early high-volume
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early high-volume hemofiltration (HVHF) at 80 ml/kg/h for 48 hours
Trial: 24011983
Drug: Functional abilities
RxNorm normalized name: plasma protein fraction Injection [Plasmanate]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Functional abilities in activities of daily living
Trial: 20434290
Drug: Medication treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication treatment intensification (TI)
Trial: 15872238
Drug: Valacyclovir (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valacyclovir (2 g twice on the day of treatment and 1 g twice the following day)
Trial: 12517199
Drug: Nebulizer group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulizer group (received nebulized albuterol)
Trial: 12517199
Drug: Spacer group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spacer group (received albuterol by metered-dose inhaler with a spacer)
Trial: 8867518
Drug: Apomorphine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apomorphine infusion (low, medium, high rates)
Trial: 6200724
Drug: Intravenous hydralazine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous hydralazine bolus (0.15 mg/kg)
Trial: 6200724
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of isosorbide dinitrate and hydralazine
Trial: 26474989
Drug: S-1 and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-1 and oxaliplatin (SOX) therapy
Trial: 26474989
Drug: S-1 and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-1 and cisplatin (CS) therapy
Trial: 22893765
Drug: Low-intensity stretching
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-intensity stretching control treatment (n = 16)
Trial: 19094450
Drug: Intravenous supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous supplementation with glutamine dipeptide (Gln) 30 g/day
Trial: 19094450
Drug: Standard amino
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard amino acid mixture (control) 25 g/day
Trial: 29509892
Drug: Conventional chest
RxNorm normalized name: Kids-Eeze Chest Relief
DrugBank: Guaifenesin (DB00874)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional chest tube treatment
Trial: 19803312
Drug: 100 mcg
RxNorm normalized name: Levo-T 100 MCG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mcg of intravenous fentanyl
Trial: 15735462
Drug: 5.25% sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5.25% sodium hypochlorite with 17% EDTA for 1 min followed by 5-ml rinse with 5.25% NaOCl
Trial: 12895193
Drug: Quinidine (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinidine (3 mg kg(‐1))
Trial: 6383760
Drug: Placebo (initial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (initial single infusion)
Trial: 31389509
Drug: Ropivacaine injection
RxNorm normalized name: ROPivacaine Injection
DrugBank: Ropivacaine (DB00296)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ropivacaine injection (0.375% at doses of 2.5 ml in each belly of the anterior and middle scalene muscles, guided by ultrasonography)
Trial: 27757595
Drug: Soy nutritional
RxNorm normalized name: soy acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy nutritional intervention (30 g/day soy protein)
Trial: 25277170
Drug: Resection of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resection of the primary tumour followed by systemic therapy (fluoropyrimidine-based chemotherapy in combination with bevacizumab)
Trial: 25277170
Drug: Systemic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic therapy only (fluoropyrimidine-based chemotherapy in combination with bevacizumab)
Trial: 20175609
Drug: Family focused
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Family focused treatment
Trial: 15734713
Drug: Physical activity
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical activity treatment designed to increase TEE by 7%
Trial: 15734713
Drug: Physical activity
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical activity treatment designed to increase TEE by 11%
Trial: 10433672
Drug: Alcohol gel
RxNorm normalized name: ALCOHOL 80 mL in 100 mL TOPICAL SOLUTION [80% Alcohol Gel]
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alcohol gel sanitizer with antimicrobial lotion soap
Trial: 10433672
Drug: Alcohol gel
RxNorm normalized name: ALCOHOL 80 mL in 100 mL TOPICAL SOLUTION [80% Alcohol Gel]
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alcohol gel sanitizer with nonantimicrobial lotion soap
Trial: 10433672
Drug: Alcohol gel
RxNorm normalized name: ALCOHOL 80 mL in 100 mL TOPICAL SOLUTION [80% Alcohol Gel]
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alcohol gel sanitizer alone
Trial: 10433672
Drug: Antimicrobial lotion
RxNorm normalized name: GAUZE,ANTIMICROBIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antimicrobial lotion soap alone
Trial: 10433672
Drug: Nonantimicrobial lotion
RxNorm normalized name: GAUZE,ANTIMICROBIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonantimicrobial lotion soap alone
Trial: 215555
Drug: Erythromycin (40-50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin (40-50 mg/kg/day)
Trial: 215555
Drug: Amoxycillin (25-30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxycillin (25-30 mg/kg/day)
Trial: 215555
Drug: Erythromycin (lower
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin (lower dosage)
Trial: 31439593
Drug: Group A
RxNorm normalized name: Blood group A IgM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group A (2 mg naloxone, max 8 mg/day)
Trial: 31439593
Drug: Group B
RxNorm normalized name: Blood group B IgM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group B (4 mg naloxone, max 16 mg/day)
Trial: 24428092
Drug: 10% onion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% onion extract in silicone derivative gel
Trial: 18038502
Drug: Vitaphenol Skin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitaphenol Skin Cream (La Jolla Spa MD, La Jolla CA) applied to half of the face twice daily for 60 days
Trial: 18038502
Drug: Placebo cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo cream applied to half of the face twice daily for 60 days
Trial: 18038502
Drug: Vitaphenol Skin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitaphenol Skin Cream
Trial: 14742357
Drug: Low-molecular-weight HES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-molecular-weight HES (HES 120; 20 mL/kg)
Trial: 14742357
Drug: High-molecular-weight HES
RxNorm normalized name: High molecular weight insulin human
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High-molecular-weight HES (HES 400; 20 mL/kg)
Trial: 1821972
Drug: Intravenous infusions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusions of clomipramine at doses 75-300 mg daily for 7 to 16 days
Trial: 1821972
Drug: Intravenous infusions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusions of maprotiline at doses 75-200 mg daily for 6 to 20 days
Trial: 7032378
Drug: 32 mg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 32 mg/d methylprednisolone
Trial: 7032378
Drug: Inhaled beta
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled beta agonists
Trial: 30235727
Drug: Hanslim (high-dose)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hanslim (high-dose)
Trial: 30235727
Drug: Hanslim (low-dose)
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Hanslim (low-dose)
Trial: 20851055
Drug: Mindfulness-based cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mindfulness-based cognitive therapy (MBCT), delivered via Internet or telephone, 8 sessions over 8 weeks
Trial: 8664221
Drug: Oestradiol (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oestradiol (5 mg/100 g)
Trial: 26920606
Drug: Aspirin plus
RxNorm normalized name: Aspirin Plus Antacid Extra Strength
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin plus cilostazol therapy
Trial: 20171665
Drug: Acitretin (35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acitretin (35 mg daily for 20 weeks)
Trial: 16814823
Drug: Single-dose tafenoquine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose tafenoquine (400mg daily x 3 days)
Trial: 16814823
Drug: Split-dose tafenoquine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Split-dose tafenoquine (200 mg twice daily x 3 days)
Trial: 15823102
Drug: Primary debulking
RxNorm normalized name: Sodium primary phosphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Primary debulking surgery followed by platinum-based chemotherapy
Trial: 9615912
Drug: Pravastatin (Pravachol),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin (Pravachol), 20 mg twice daily for 12, 24, 48 and 72 hours preoperatively
Trial: 3683021
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid 1000 mg
Trial: 30259621
Drug: Dapagliflozin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dapagliflozin (10 mg) plus Pioglitazone (30 mg)
Trial: 30259621
Drug: Dapagliflozin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dapagliflozin (10 mg) alone
Trial: 25795524
Drug: Affect Labeling
RxNorm normalized name: lobeline
DrugBank: Lobeline (DB05137)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Affect Labeling during exposure therapy
Trial: 18786258
Drug: Belimumab (1.0,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Belimumab (1.0, 4.0, 10, and 20 mg/kg)
Trial: 18786258
Drug: Belimumab (two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Belimumab (two doses)
Trial: 10369424
Drug: Repaglinide (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repaglinide (0.5 mg three times/day preprandially, adjusted to 1, 2 or 4 mg)
Trial: 10369424
Drug: Glyburide (starting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glyburide (starting dose of 2.5 mg before breakfast, adjusted to 5 or 10 mg)
Trial: 7537355
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human growth hormone (0.25 U/kg/week)
Trial: 27263034
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (standard statin therapy)
Trial: 20381657
Drug: Evidence-based antiplatelet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evidence-based antiplatelet and antithrombin therapies during the initial 24 hours of hospital admission
Trial: 15523399
Drug: Transdermal nicotine
RxNorm normalized name: nicotine Transdermal System
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal nicotine patch 25 mg per day
Trial: 11122841
Drug: Combined chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined chemotherapy plus radiotherapy
Trial: 11122841
Drug: Initial chemotherapy
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Initial chemotherapy followed by radiation therapy (combined modality therapy)
Trial: 27100726
Drug: Nigella sativa
RxNorm normalized name: NIGELLA SATIVA SEED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nigella sativa oil (1 gram in two divided doses)
Trial: 18339258
Drug: Intramuscular progesterone
RxNorm normalized name: Progesterone
DrugBank: Progesterone (DB00396)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intramuscular progesterone (IMP) 50 mg daily
Trial: 18339258
Drug: Progesterone vaginal
RxNorm normalized name: progesterone Vaginal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Progesterone vaginal gel (VGP) 90 mg once daily
Trial: 18339258
Drug: Progesterone vaginal
RxNorm normalized name: progesterone Vaginal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Progesterone vaginal gel (VGP) 90 mg twice daily
Trial: 12869088
Drug: Quinine dihydrochloride
RxNorm normalized name: quinine dihydrochloride
DrugBank: Quinine (DB00468)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Quinine dihydrochloride (Qn) with pentoxifylline (Px) (10 mg/kg/day for 3 days)
Trial: 2861527
Drug: Triamterene (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triamterene (50 mg/day)
Trial: 2861527
Drug: Amiloride (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amiloride (5 mg/day)
Trial: 2861527
Drug: Triamterene-containing combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triamterene-containing combination diuretic
Trial: 29193093
Drug: Daily breakfast
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily breakfast consumption (BFAST; ≥700 kcal before 11.00 h)
Trial: 23656841
Drug: Levomilnacipran SR
RxNorm normalized name: Levomilnacipran
DrugBank: Levomilnacipran (DB08918)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Levomilnacipran SR (75 mg or 100 mg)
Trial: 19356393
Drug: Controlled release
RxNorm normalized name: EpiCeram Controlled Release Skin Barrier Emulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled release cyclobenzaprine tablet (20 mg)